antipyrine has been researched along with Alcoholic Hepatitis in 2 studies
Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present studies were designed to provide careful measures of effects of oxandrolone, an anabolic steroid, intravenous nutritional supplementation, and the combination of these two treatments on liver functions, metabolic balances, nitrogen metabolism, and nutritional status in patients with moderate to severe alcoholic hepatitis." | 9.07 | A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function. ( Bonkovsky, HL; Fiellin, DA; Galambos, JT; Simon, D; Slaker, DP; Smith, GS, 1991) |
| "The present studies were designed to provide careful measures of effects of oxandrolone, an anabolic steroid, intravenous nutritional supplementation, and the combination of these two treatments on liver functions, metabolic balances, nitrogen metabolism, and nutritional status in patients with moderate to severe alcoholic hepatitis." | 5.07 | A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function. ( Bonkovsky, HL; Fiellin, DA; Galambos, JT; Simon, D; Slaker, DP; Smith, GS, 1991) |
| "Eight patients with biopsy-proven chronic alcoholic hepatitis were investigated before and after a 10-day, as well as after a further 30-day, treatment with (+)-cyanidanol-3 (Catergen), 3000 mg/day orally." | 1.27 | Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease. ( Beró, T; Horváth, T; Jávor, T; Kádas, I; Pakodi, F; Pár, A, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pár, A | 1 |
| Horváth, T | 1 |
| Beró, T | 1 |
| Kádas, I | 1 |
| Pakodi, F | 1 |
| Jávor, T | 1 |
| Bonkovsky, HL | 1 |
| Fiellin, DA | 1 |
| Smith, GS | 1 |
| Slaker, DP | 1 |
| Simon, D | 1 |
| Galambos, JT | 1 |
1 trial available for antipyrine and Alcoholic Hepatitis
| Article | Year |
|---|---|
A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function.
Topics: Adult; Analysis of Variance; Antipyrine; Cardiac Output; Combined Modality Therapy; Female; Galactos | 1991 |
1 other study available for antipyrine and Alcoholic Hepatitis
| Article | Year |
|---|---|
Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease.
Topics: Adult; Antipyrine; Aspartate Aminotransferases; Benzopyrans; Catechin; gamma-Glutamyltransferase; Gl | 1984 |